Retrospective Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Aug 16, 2023; 11(23): 5462-5467
Published online Aug 16, 2023. doi: 10.12998/wjcc.v11.i23.5462
Progress of ulcerative colitis patients during the COVID-19 pandemic
Toshikuni Suda, Morio Takahashi, Yasumi Katayama, Koichi Soga, Ikuhiro Kobori, Yumi Kusano, Masaya Tamano
Toshikuni Suda, Yasumi Katayama, Koichi Soga, Ikuhiro Kobori, Yumi Kusano, Masaya Tamano, Division of Gastroenterology, Dokkyo Medical University Saitama Medical Center, Saitama 343-8555, Japan
Morio Takahashi, Division of Gastroenterology, Morio Clinic, Saitama 343-0808, Japan
Author contributions: Suda T recruited patients and wrote the paper; Takahashi M designed the study and analyzed data; Soga K revised the manuscript; Kobori I and Kusano Y provided clinical advice; and Tamano M and Katayama Y supervised the study.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of Dokkyo Medical University Saitama Medical Center (Approval No. 20100).
Informed consent statement: All patients provided informed consent to participate in this study and agreed to publication of the research results.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Toshikuni Suda, Doctor, MD, PhD, Doctor, Instructor, Staff Physician, Division of Gastroenterology, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya-Shi, Saitama 343-8555, Japan. toshikuni.suda@gmail.com
Received: May 24, 2023
Peer-review started: May 24, 2023
First decision: June 20, 2023
Revised: June 30, 2023
Accepted: July 25, 2023
Article in press: July 25, 2023
Published online: August 16, 2023
Core Tip

Core Tip: Previously, we demonstrated that the first wave of coronavirus disease 2019 (COVID-19) pandemic caused exacerbation in ulcerative colitis (UC) patients. Impact of the successive waves of the pandemic is of interest. We adopted the identical group of patients who were included in our previous study indicating the impact of the first wave in 2020. Disease activity of UC patients, aggravated by the stress of the first wave of COVID-19 in 2020, recovered significantly in 2021 and remained stable in 2022, despite persistence of the pandemic.